These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 14968353)
41. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052 [TBL] [Abstract][Full Text] [Related]
42. Measuring of the heparin leakage into the circulation from central venous catheters--an in vivo study. Markota I; Markota D; Tomic M Nephrol Dial Transplant; 2009 May; 24(5):1550-3. PubMed ID: 19075195 [TBL] [Abstract][Full Text] [Related]
44. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports. Manfredi JA; Wall RP; Sane DC; Braden GA Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599 [TBL] [Abstract][Full Text] [Related]
45. [Management of catheter-related upper extremity deep vein thrombosis]. Linnemann B; Lindhoff-Last E Zentralbl Chir; 2013 Dec; 138 Suppl 2():e86-94. PubMed ID: 23575524 [TBL] [Abstract][Full Text] [Related]
46. Do bevacizumab solutions interact with silicone or polyurethane catheters during an infusion through implantable venous access ports? Tokhadzé N; Chennell P; Cueff R; Sautou V J R Soc Interface; 2019 Sep; 16(158):20180721. PubMed ID: 31551048 [TBL] [Abstract][Full Text] [Related]
47. Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples. Lorenz RG; Garrett N; Turk JW; Scott MG Transplantation; 1991 Dec; 52(6):1109-10. PubMed ID: 1750077 [No Abstract] [Full Text] [Related]
48. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. Lepor NE Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621 [TBL] [Abstract][Full Text] [Related]
49. Retention of lepirudin at the tip of a silicone catheter: a better catheter flush solution? Horne MK; Inkellis E Support Care Cancer; 2004 Apr; 12(4):278-81. PubMed ID: 14968353 [TBL] [Abstract][Full Text] [Related]
50. Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices. Horne MK; McCloskey DJ; Calis K; Wesley R; Childs R; Kasten-Sportes C Pharmacotherapy; 2006 Sep; 26(9):1262-7. PubMed ID: 16945048 [TBL] [Abstract][Full Text] [Related]
53. In vitro evaluation of relative perforating potential of central venous catheters: comparison of materials, selected models, number of lumens, and angles of incidence to simulated membrane. Gravenstein N; Blackshear RH J Clin Monit; 1991 Jan; 7(1):1-6. PubMed ID: 1999693 [TBL] [Abstract][Full Text] [Related]
54. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445 [TBL] [Abstract][Full Text] [Related]